Medical Subject Headings
MeSH Tree Structures - 2014
E05 - Investigative Techniques
- Investigative Techniques [E05]
- Accelerometry [E05.003]
- Airway Extubation [E05.008]
- Animal Experimentation [E05.017]
- Animal Identification Systems [E05.035]
- Anthropometry [E05.041]
- Body Weights and Measures [E05.041.124]
- Body Mass Index [E05.041.124.125]
- Body Size [E05.041.124.160]
- Body Surface Area [E05.041.124.231]
- Organ Size [E05.041.124.715]
- Skinfold Thickness [E05.041.124.803]
- Tumor Burden [E05.041.124.892]
- Waist-Hip Ratio [E05.041.124.946]
- Cephalometry [E05.041.250]
- Odontometry [E05.041.650]
- Pelvimetry [E05.041.690]
- Body Weights and Measures [E05.041.124]
- Artifacts [E05.047]
- Autoanalysis [E05.059]
- Automation, Laboratory [E05.064]
- Autopsy [E05.070]
- Biological Assay [E05.091]
- Biomedical Enhancement [E05.104]
- Bioprinting [E05.111]
- Bone Demineralization Technique [E05.118]
- Calibration [E05.140]
- Calorimetry [E05.145]
- Catheterization [E05.157]
- Cementation [E05.170]
- Centrifugation [E05.181]
- Chemistry Techniques, Analytical [E05.196]
- Activation Analysis [E05.196.039]
- Analytic Sample Preparation Methods [E05.196.059]
- Binding, Competitive [E05.196.080]
- Biuret Reaction [E05.196.085]
- Calorimetry [E05.196.131]
- Chemical Precipitation [E05.196.150]
- Chemical Fractionation [E05.196.155]
- Chromatography [E05.196.181]
- Chromatography, Gas [E05.196.181.349]
- Chromatography, Liquid [E05.196.181.400]
- Capillary Electrochromatography [E05.196.181.400.150]
- Chromatography, Affinity [E05.196.181.400.170]
- Chromatography, Gel [E05.196.181.400.250]
- Chromatography, High Pressure Liquid [E05.196.181.400.300]
- Chromatography, Ion Exchange [E05.196.181.400.383]
- Chromatography, Paper [E05.196.181.400.454]
- Chromatography, Reverse-Phase [E05.196.181.400.495]
- Chromatography, Thin Layer [E05.196.181.400.537]
- Countercurrent Distribution [E05.196.181.400.555]
- Chromatography, Micellar Electrokinetic Capillary [E05.196.181.500]
- Chromatography, Supercritical Fluid [E05.196.181.750]
- Countercurrent Distribution [E05.196.278]
- Crystallization [E05.196.300]
- Crystallography [E05.196.309]
- Desiccation [E05.196.335]
- Deuterium Exchange Measurement [E05.196.344]
- Dialysis [E05.196.353]
- Differential Thermal Analysis [E05.196.370]
- Electroosmosis [E05.196.385]
- Electrophoresis [E05.196.401]
- Blood Protein Electrophoresis [E05.196.401.076]
- Blotting, Northern [E05.196.401.095]
- Blotting, Southern [E05.196.401.114]
- Blotting, Southwestern [E05.196.401.133]
- Blotting, Western [E05.196.401.143]
- Electrophoresis, Agar Gel [E05.196.401.153]
- Electrophoresis, Capillary [E05.196.401.190]
- Electrophoresis, Cellulose Acetate [E05.196.401.200]
- Electrophoresis, Gel, Pulsed-Field [E05.196.401.220]
- Electrophoresis, Gel, Two-Dimensional [E05.196.401.250]
- Electrophoresis, Paper [E05.196.401.319]
- Electrophoresis, Polyacrylamide Gel [E05.196.401.402]
- Electrophoresis, Starch Gel [E05.196.401.485]
- Electrophoretic Mobility Shift Assay [E05.196.401.500]
- Immunoelectrophoresis [E05.196.401.568]
- Isoelectric Focusing [E05.196.401.663]
- Isotachophoresis [E05.196.401.831]
- Enzyme Assays [E05.196.427]
- Filtration [E05.196.454]
- Flow Injection Analysis [E05.196.460]
- Glucose Clamp Technique [E05.196.500]
- Mass Spectrometry [E05.196.566]
- Gas Chromatography-Mass Spectrometry [E05.196.566.500]
- Spectrometry, Mass, Electrospray Ionization [E05.196.566.600]
- Spectrometry, Mass, Fast Atom Bombardment [E05.196.566.750]
- Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization [E05.196.566.755]
- Spectrometry, Mass, Secondary Ion [E05.196.566.760]
- Tandem Mass Spectrometry [E05.196.566.880]
- Microchemistry [E05.196.620]
- Microchip Analytical Procedures [E05.196.630]
- Molecular Imprinting [E05.196.655]
- Nucleotide Mapping [E05.196.680]
- Osmometry [E05.196.690]
- Peptide Mapping [E05.196.700]
- Photometry [E05.196.712]
- Densitometry [E05.196.712.224]
- Luminescent Measurements [E05.196.712.516]
- Bioluminescence Resonance Energy Transfer Techniques [E05.196.712.516.099]
- Fluorometry [E05.196.712.516.600]
- Nephelometry and Turbidimetry [E05.196.712.650]
- Spectrophotometry [E05.196.712.726]
- Polarography [E05.196.749]
- Quartz Crystal Microbalance Techniques [E05.196.778]
- Refractometry [E05.196.808]
- Scattering, Radiation [E05.196.822]
- Spectrum Analysis [E05.196.867]
- Circular Dichroism [E05.196.867.151]
- Dielectric Spectroscopy [E05.196.867.335]
- Magnetic Resonance Spectroscopy [E05.196.867.519]
- Optical Rotatory Dispersion [E05.196.867.576]
- Photoelectron Spectroscopy [E05.196.867.618]
- Pulse Radiolysis [E05.196.867.660]
- Spectrometry, Fluorescence [E05.196.867.726]
- Spectrometry, Gamma [E05.196.867.776]
- Spectrometry, X-Ray Emission [E05.196.867.800]
- Spectrophotometry [E05.196.867.826]
- Spectroscopy, Electron Energy-Loss [E05.196.867.838]
- Spectroscopy, Near-Infrared [E05.196.867.851]
- Spectrum Analysis, Raman [E05.196.867.890]
- Sun Protection Factor [E05.196.867.917]
- Terahertz Spectroscopy [E05.196.867.945]
- X-Ray Absorption Spectroscopy [E05.196.867.972]
- Spin Trapping [E05.196.885]
- Surface Plasmon Resonance [E05.196.890]
- Thermogravimetry [E05.196.904]
- Titrimetry [E05.196.922]
- Ultracentrifugation [E05.196.941]
- Chromophore-Assisted Light Inactivation [E05.198]
- Clinical Laboratory Techniques [E05.200]
- Clinical Chemistry Tests [E05.200.124]
- Blood Chemical Analysis [E05.200.124.100]
- Blood Gas Analysis [E05.200.124.100.100]
- Blood Glucose Self-Monitoring [E05.200.124.100.105]
- Blood Protein Electrophoresis [E05.200.124.100.110]
- Blood Urea Nitrogen [E05.200.124.100.115]
- Dried Blood Spot Testing [E05.200.124.100.232]
- Glucose Clamp Technique [E05.200.124.100.350]
- Glucose Tolerance Test [E05.200.124.100.355]
- Lactose Tolerance Test [E05.200.124.100.450]
- Petrosal Sinus Sampling [E05.200.124.100.600]
- Clinical Enzyme Tests [E05.200.124.200]
- Esophageal pH Monitoring [E05.200.124.210]
- Gastric Acidity Determination [E05.200.124.300]
- Limulus Test [E05.200.124.470]
- Urinalysis [E05.200.124.810]
- Blood Chemical Analysis [E05.200.124.100]
- Cytological Techniques [E05.200.500]
- Cell Count [E05.200.500.195]
- Cell Culture Techniques [E05.200.500.223]
- Cell Migration Assays [E05.200.500.335]
- Cell Separation [E05.200.500.363]
- Cell Tracking [E05.200.500.373]
- Colony-Forming Units Assay [E05.200.500.383]
- Cytodiagnosis [E05.200.500.384]
- Amniocentesis [E05.200.500.384.050]
- Biopsy [E05.200.500.384.100]
- Biopsy, Needle [E05.200.500.384.100.119]
- Chorionic Villi Sampling [E05.200.500.384.100.149]
- Conization [E05.200.500.384.100.160]
- Image-Guided Biopsy [E05.200.500.384.100.370]
- Papanicolaou Test [E05.200.500.384.100.422]
- Sentinel Lymph Node Biopsy [E05.200.500.384.100.580]
- Vaginal Smears [E05.200.500.384.100.800]
- Chorionic Villi Sampling [E05.200.500.384.150]
- Cytopathogenic Effect, Viral [E05.200.500.384.235]
- Karyometry [E05.200.500.384.467]
- Cytogenetic Analysis [E05.200.500.385]
- Cytophotometry [E05.200.500.386]
- Drug Screening Assays, Antitumor [E05.200.500.388]
- Enzyme-Linked Immunospot Assay [E05.200.500.508]
- Histocytochemistry [E05.200.500.607]
- Histocytological Preparation Techniques [E05.200.500.620]
- Microtomy [E05.200.500.620.530]
- Replica Techniques [E05.200.500.620.620]
- Staining and Labeling [E05.200.500.620.670]
- Chromosome Banding [E05.200.500.620.670.130]
- In Situ Hybridization [E05.200.500.620.670.325]
- Negative Staining [E05.200.500.620.670.520]
- Neuroanatomical Tract-Tracing Techniques [E05.200.500.620.670.570]
- Periodic Acid-Schiff Reaction [E05.200.500.620.670.620]
- Prussian Blue Reaction [E05.200.500.620.670.660]
- Shadowing (Histology) [E05.200.500.620.670.770]
- Silver Staining [E05.200.500.620.670.780]
- Tissue Embedding [E05.200.500.620.720]
- Tissue Preservation [E05.200.500.620.760]
- Genetic Testing [E05.200.562]
- Hematologic Tests [E05.200.625]
- Blood Cell Count [E05.200.625.107]
- Blood Coagulation Tests [E05.200.625.115]
- Blood Grouping and Crossmatching [E05.200.625.120]
- Blood Sedimentation [E05.200.625.125]
- Bone Marrow Examination [E05.200.625.135]
- Erythrocyte Aggregation [E05.200.625.225]
- Erythrocyte Indices [E05.200.625.230]
- Fibrin Clot Lysis Time [E05.200.625.265]
- FIGLU Test [E05.200.625.300]
- Hematocrit [E05.200.625.400]
- Hemoglobinometry [E05.200.625.410]
- Osmotic Fragility [E05.200.625.550]
- Platelet Function Tests [E05.200.625.625]
- Schilling Test [E05.200.625.750]
- Histological Techniques [E05.200.750]
- Autoradiography [E05.200.750.132]
- Decalcification Technique [E05.200.750.288]
- Histocytochemistry [E05.200.750.551]
- Histocytological Preparation Techniques [E05.200.750.600]
- Microdissection [E05.200.750.600.520]
- Microtomy [E05.200.750.600.530]
- Replica Techniques [E05.200.750.600.620]
- Staining and Labeling [E05.200.750.600.670]
- Chromosome Banding [E05.200.750.600.670.130]
- In Situ Hybridization [E05.200.750.600.670.325]
- Negative Staining [E05.200.750.600.670.520]
- Neuroanatomical Tract-Tracing Techniques [E05.200.750.600.670.570]
- Prussian Blue Reaction [E05.200.750.600.670.660]
- Shadowing (Histology) [E05.200.750.600.670.770]
- Silver Staining [E05.200.750.600.670.780]
- Tissue Embedding [E05.200.750.600.720]
- Tissue Preservation [E05.200.750.600.760]
- Immunologic Tests [E05.200.812]
- Antibody-Coated Bacteria Test, Urinary [E05.200.812.049]
- Basophil Degranulation Test [E05.200.812.100]
- Cell Migration Assays [E05.200.812.125]
- Cytotoxicity Tests, Immunologic [E05.200.812.160]
- Hemolytic Plaque Technique [E05.200.812.375]
- Histocompatibility Testing [E05.200.812.385]
- Immune Adherence Reaction [E05.200.812.400]
- Immunophenotyping [E05.200.812.447]
- Interferon-gamma Release Tests [E05.200.812.453]
- Leukocyte Adherence Inhibition Test [E05.200.812.460]
- Lymphocyte Activation [E05.200.812.482]
- Monitoring, Immunologic [E05.200.812.505]
- Pregnancy Tests, Immunologic [E05.200.812.620]
- Rosette Formation [E05.200.812.706]
- Serologic Tests [E05.200.812.735]
- Agglutination Tests [E05.200.812.735.050]
- AIDS Serodiagnosis [E05.200.812.735.060]
- Complement Fixation Tests [E05.200.812.735.150]
- Complement Hemolytic Activity Assay [E05.200.812.735.155]
- Hemadsorption Inhibition Tests [E05.200.812.735.360]
- Hemagglutination Inhibition Tests [E05.200.812.735.370]
- Neutralization Tests [E05.200.812.735.550]
- Precipitin Tests [E05.200.812.735.645]
- Radioallergosorbent Test [E05.200.812.735.830]
- Radioimmunoprecipitation Assay [E05.200.812.735.840]
- Serum Bactericidal Antibody Assay [E05.200.812.735.845]
- Syphilis Serodiagnosis [E05.200.812.735.850]
- Serotyping [E05.200.812.742]
- Skin Tests [E05.200.812.871]
- Metabolic Clearance Rate [E05.200.843]
- Microbiological Techniques [E05.200.875]
- Axenic Culture [E05.200.875.074]
- Bacteriological Techniques [E05.200.875.150]
- Colony Count, Microbial [E05.200.875.220]
- Microbial Sensitivity Tests [E05.200.875.595]
- Mycological Typing Techniques [E05.200.875.610]
- Serial Passage [E05.200.875.837]
- Viral Load [E05.200.875.950]
- Virus Cultivation [E05.200.875.970]
- Virus Inactivation [E05.200.875.977]
- Xenodiagnosis [E05.200.875.985]
- Molecular Diagnostic Techniques [E05.200.880]
- Neonatal Screening [E05.200.910]
- Occult Blood [E05.200.925]
- Parasite Load [E05.200.932]
- Parasitic Sensitivity Tests [E05.200.940]
- Pregnancy Tests [E05.200.970]
- Radioligand Assay [E05.200.985]
- Semen Analysis [E05.200.992]
- Sex Determination Analysis [E05.200.996]
- Specimen Handling [E05.200.998]
- Biopsy [E05.200.998.054]
- Biopsy, Needle [E05.200.998.054.119]
- Chorionic Villi Sampling [E05.200.998.054.149]
- Conization [E05.200.998.054.160]
- Image-Guided Biopsy [E05.200.998.054.370]
- Papanicolaou Test [E05.200.998.054.422]
- Sentinel Lymph Node Biopsy [E05.200.998.054.580]
- Spinal Puncture [E05.200.998.054.790]
- Vaginal Smears [E05.200.998.054.800]
- Blood Specimen Collection [E05.200.998.110]
- Chorionic Villi Sampling [E05.200.998.165]
- Dissection [E05.200.998.221]
- DNA Contamination [E05.200.998.293]
- Paracentesis [E05.200.998.329]
- Spinal Puncture [E05.200.998.683]
- Urine Specimen Collection [E05.200.998.762]
- Biopsy [E05.200.998.054]
- Clinical Chemistry Tests [E05.200.124]
- Constriction [E05.225]
- Containment of Biohazards [E05.235]
- Culture Techniques [E05.240]
- Axenic Culture [E05.240.124]
- Cell Culture Techniques [E05.240.249]
- Cell Engineering [E05.240.311]
- Coculture Techniques [E05.240.374]
- Embryo Culture Techniques [E05.240.468]
- Organ Culture Techniques [E05.240.484]
- Plant Somatic Embryogenesis Techniques [E05.240.550]
- Tissue Culture Techniques [E05.240.617]
- Cytological Techniques [E05.242]
- Cell Count [E05.242.195]
- Cell Culture Techniques [E05.242.223]
- Cell Fractionation [E05.242.251]
- Cell Fusion [E05.242.307]
- Cell Migration Assays [E05.242.335]
- Cell Separation [E05.242.363]
- Cell Tracking [E05.242.373]
- Colony-Forming Units Assay [E05.242.383]
- Cytodiagnosis [E05.242.384]
- Amniocentesis [E05.242.384.050]
- Biopsy [E05.242.384.100]
- Chorionic Villi Sampling [E05.242.384.150]
- Cytopathogenic Effect, Viral [E05.242.384.235]
- Karyometry [E05.242.384.467]
- Cytogenetic Analysis [E05.242.385]
- Cytophotometry [E05.242.386]
- Drug Screening Assays, Antitumor [E05.242.388]
- Electroporation [E05.242.448]
- Enzyme-Linked Immunospot Assay [E05.242.508]
- Metabolic Flux Analysis [E05.242.654]
- Patch-Clamp Techniques [E05.242.800]
- Single-Cell Analysis [E05.242.900]
- Stem Cell Research [E05.242.950]
- Decision Support Techniques [E05.245]
- Dermatoglyphics [E05.256]
- Diet, Atherogenic [E05.263]
- Diet, Cariogenic [E05.270]
- Dilatation [E05.284]
- Drug Discovery [E05.295]
- Ecological Parameter Monitoring [E05.298]
- Electrochemical Techniques [E05.301]
- Conductometry [E05.301.160]
- Electrolysis [E05.301.250]
- Electroosmosis [E05.301.270]
- Electrophoresis [E05.301.300]
- Blood Protein Electrophoresis [E05.301.300.049]
- Blotting, Northern [E05.301.300.074]
- Blotting, Southern [E05.301.300.087]
- Blotting, Southwestern [E05.301.300.093]
- Blotting, Western [E05.301.300.096]
- Electrophoresis, Agar Gel [E05.301.300.100]
- Electrophoresis, Capillary [E05.301.300.190]
- Electrophoresis, Cellulose Acetate [E05.301.300.200]
- Electrophoresis, Gel, Pulsed-Field [E05.301.300.220]
- Electrophoresis, Gel, Two-Dimensional [E05.301.300.230]
- Electrophoresis, Paper [E05.301.300.236]
- Electrophoresis, Polyacrylamide Gel [E05.301.300.319]
- Electrophoresis, Starch Gel [E05.301.300.402]
- Immunoelectrophoresis [E05.301.300.568]
- Iontophoresis [E05.301.300.575]
- Isoelectric Focusing [E05.301.300.663]
- Isotachophoresis [E05.301.300.831]
- Electroporation [E05.301.500]
- Polarography [E05.301.700]
- Potentiometry [E05.301.710]
- Embryo Research [E05.313]
- Endpoint Determination [E05.315]
- Epidemiologic Methods [E05.318]
- Contact Tracing [E05.318.270]
- Data Collection [E05.318.308]
- Geriatric Assessment [E05.318.308.225]
- Health Impact Assessment [E05.318.308.237]
- Health Surveys [E05.318.308.250]
- Health Care Surveys [E05.318.308.335]
- Interviews as Topic [E05.318.308.420]
- Lot Quality Assurance Sampling [E05.318.308.461]
- Narration [E05.318.308.502]
- Nutrition Assessment [E05.318.308.585]
- Questionnaires [E05.318.308.750]
- Records as Topic [E05.318.308.940]
- Birth Certificates [E05.318.308.940.250]
- Death Certificates [E05.318.308.940.350]
- Dental Records [E05.318.308.940.375]
- Hospital Records [E05.318.308.940.425]
- Medical Records [E05.318.308.940.968]
- Nursing Records [E05.318.308.940.984]
- Registries [E05.318.308.970]
- Vital Statistics [E05.318.308.985]
- Life Expectancy [E05.318.308.985.450]
- Life Tables [E05.318.308.985.475]
- Morbidity [E05.318.308.985.525]
- Mortality [E05.318.308.985.550]
- Cause of Death [E05.318.308.985.550.250]
- Child Mortality [E05.318.308.985.550.287]
- Fatal Outcome [E05.318.308.985.550.325]
- Fetal Mortality [E05.318.308.985.550.362]
- Hospital Mortality [E05.318.308.985.550.400]
- Infant Mortality [E05.318.308.985.550.475]
- Maternal Mortality [E05.318.308.985.550.500]
- Mortality, Premature [E05.318.308.985.550.550]
- Perinatal Mortality [E05.318.308.985.550.700]
- Survival Rate [E05.318.308.985.550.900]
- Pregnancy Rate [E05.318.308.985.775]
- Disease Notification [E05.318.362]
- Epidemiological Monitoring [E05.318.375]
- Geographic Mapping [E05.318.389]
- Molecular Epidemiology [E05.318.416]
- Sentinel Surveillance [E05.318.650]
- Statistics as Topic [E05.318.740]
- Actuarial Analysis [E05.318.740.100]
- Analysis of Variance [E05.318.740.150]
- Area Under Curve [E05.318.740.200]
- Biometry [E05.318.740.225]
- Biostatistics [E05.318.740.237]
- Cluster Analysis [E05.318.740.250]
- Confidence Intervals [E05.318.740.275]
- Data Interpretation, Statistical [E05.318.740.300]
- Discriminant Analysis [E05.318.740.350]
- Factor Analysis, Statistical [E05.318.740.400]
- Matched-Pair Analysis [E05.318.740.475]
- Models, Statistical [E05.318.740.500]
- Monte Carlo Method [E05.318.740.525]
- Principal Component Analysis [E05.318.740.562]
- Probability [E05.318.740.600]
- Bayes Theorem [E05.318.740.600.200]
- Likelihood Functions [E05.318.740.600.400]
- Markov Chains [E05.318.740.600.500]
- Odds Ratio [E05.318.740.600.600]
- Position-Specific Scoring Matrices [E05.318.740.600.650]
- Propensity Score [E05.318.740.600.675]
- Proportional Hazards Models [E05.318.740.600.700]
- Risk [E05.318.740.600.800]
- Uncertainty [E05.318.740.600.900]
- Regression Analysis [E05.318.740.750]
- Sensitivity and Specificity [E05.318.740.872]
- Spatial Analysis [E05.318.740.933]
- Statistical Distributions [E05.318.740.994]
- Statistics, Nonparametric [E05.318.740.995]
- Stochastic Processes [E05.318.740.996]
- Survival Analysis [E05.318.740.998]
- Epidemiologic Study Characteristics as Topic [E05.318.760]
- Epidemiologic Studies [E05.318.760.500]
- Clinical Trials as Topic [E05.318.760.535]
- Clinical Trials, Phase I as Topic [E05.318.760.535.200]
- Clinical Trials, Phase II as Topic [E05.318.760.535.210]
- Clinical Trials, Phase III as Topic [E05.318.760.535.220]
- Clinical Trials, Phase IV as Topic [E05.318.760.535.230]
- Controlled Clinical Trials as Topic [E05.318.760.535.365]
- Multicenter Studies as Topic [E05.318.760.535.500]
- Observational Study as Topic [E05.318.760.535.750]
- Feasibility Studies [E05.318.760.550]
- Intervention Studies [E05.318.760.565]
- Pilot Projects [E05.318.760.750]
- Sampling Studies [E05.318.760.875]
- Twin Studies as Topic [E05.318.760.900]
- Epidemiologic Research Design [E05.318.780]
- Control Groups [E05.318.780.074]
- Cross-Over Studies [E05.318.780.150]
- Double-Blind Method [E05.318.780.300]
- Genome-Wide Association Study [E05.318.780.392]
- Lost to Follow-Up [E05.318.780.438]
- Matched-Pair Analysis [E05.318.780.485]
- Meta-Analysis as Topic [E05.318.780.500]
- Random Allocation [E05.318.780.700]
- Reproducibility of Results [E05.318.780.725]
- Sample Size [E05.318.780.762]
- Sensitivity and Specificity [E05.318.780.800]
- Single-Blind Method [E05.318.780.850]
- Equipment Design [E05.320]
- Equipment Failure [E05.325]
- Equipment Reuse [E05.328]
- Equipment Safety [E05.330]
- Ergometry [E05.333]
- Euthanasia, Animal [E05.335]
- Evaluation Studies as Topic [E05.337]
- Clinical Trials as Topic [E05.337.250]
- Clinical Trials, Phase I as Topic [E05.337.250.200]
- Clinical Trials, Phase II as Topic [E05.337.250.210]
- Clinical Trials, Phase III as Topic [E05.337.250.220]
- Clinical Trials, Phase IV as Topic [E05.337.250.230]
- Controlled Clinical Trials as Topic [E05.337.250.365]
- Early Termination of Clinical Trials [E05.337.250.432]
- Multicenter Studies as Topic [E05.337.250.500]
- Device Approval [E05.337.275]
- Drug Approval [E05.337.300]
- Drug Evaluation [E05.337.425]
- Drug Evaluation, Preclinical [E05.337.550]
- Feasibility Studies [E05.337.675]
- Pilot Projects [E05.337.737]
- Product Surveillance, Postmarketing [E05.337.800]
- Program Evaluation [E05.337.820]
- Reproducibility of Results [E05.337.851]
- Validation Studies as Topic [E05.337.925]
- Clinical Trials as Topic [E05.337.250]
- Fetal Research [E05.349]
- Finite Element Analysis [E05.355]
- Food Analysis [E05.362]
- Fourier Analysis [E05.377]
- Genetic Techniques [E05.393]
- Chromatin Immunoprecipitation [E05.393.170]
- Chromosome Mapping [E05.393.183]
- Cloning, Molecular [E05.393.220]
- Cloning, Organism [E05.393.240]
- Contig Mapping [E05.393.260]
- Crosses, Genetic [E05.393.281]
- Cytogenetic Analysis [E05.393.285]
- DNA Fingerprinting [E05.393.290]
- DNA Footprinting [E05.393.300]
- Gene Expression Profiling [E05.393.332]
- Gene Targeting [E05.393.335]
- Gene Transfer Techniques [E05.393.350]
- Genetic Association Studies [E05.393.385]
- Genetic Engineering [E05.393.420]
- Genetic Testing [E05.393.435]
- Genotyping Techniques [E05.393.442]
- Heterozygote Detection [E05.393.450]
- Human Papillomavirus DNA Tests [E05.393.462]
- In Situ Nick-End Labeling [E05.393.475]
- Molecular Diagnostic Techniques [E05.393.520]
- Molecular Epidemiology [E05.393.522]
- Molecular Probe Techniques [E05.393.525]
- Biotinylation [E05.393.525.085]
- Blotting, Northern [E05.393.525.100]
- Blotting, Southern [E05.393.525.150]
- Blotting, Southwestern [E05.393.525.225]
- Blotting, Western [E05.393.525.262]
- Branched DNA Signal Amplification Assay [E05.393.525.300]
- Oligonucleotide Array Sequence Analysis [E05.393.525.640]
- Protein Array Analysis [E05.393.525.680]
- Random Amplified Polymorphic DNA Technique [E05.393.525.700]
- Two-Hybrid System Techniques [E05.393.525.870]
- Molecular Typing [E05.393.542]
- Mutagenicity Tests [E05.393.560]
- Nuclear Transfer Techniques [E05.393.580]
- Nuclease Protection Assays [E05.393.600]
- Nucleic Acid Amplification Techniques [E05.393.620]
- Ligase Chain Reaction [E05.393.620.311]
- Polymerase Chain Reaction [E05.393.620.500]
- Amplified Fragment Length Polymorphism Analysis [E05.393.620.500.324]
- Multiplex Polymerase Chain Reaction [E05.393.620.500.487]
- Primed In Situ Labeling [E05.393.620.500.650]
- Random Amplified Polymorphic DNA Technique [E05.393.620.500.687]
- Real-Time Polymerase Chain Reaction [E05.393.620.500.706]
- Reverse Transcriptase Polymerase Chain Reaction [E05.393.620.500.725]
- Self-Sustained Sequence Replication [E05.393.620.700]
- Nucleic Acid Denaturation [E05.393.640]
- Nucleic Acid Hybridization [E05.393.661]
- Optogenetics [E05.393.667]
- Pedigree [E05.393.673]
- Restriction Mapping [E05.393.712]
- Reverse Genetics [E05.393.731]
- Sequence Alignment [E05.393.751]
- Sequence Analysis [E05.393.760]
- High-Throughput Nucleotide Sequencing [E05.393.760.319]
- Molecular Sequence Annotation [E05.393.760.479]
- Oligonucleotide Array Sequence Analysis [E05.393.760.640]
- Position-Specific Scoring Matrices [E05.393.760.670]
- Sequence Analysis, DNA [E05.393.760.700]
- Sequence Analysis, Protein [E05.393.760.705]
- Sequence Analysis, RNA [E05.393.760.710]
- Hardness Tests [E05.417]
- Human Experimentation [E05.445]
- Immersion [E05.466]
- Immobilization [E05.472]
- Immunologic Techniques [E05.478]
- Epitope Mapping [E05.478.274]
- Fluorescent Antibody Technique [E05.478.412]
- Immunization [E05.478.550]
- Immunoassay [E05.478.566]
- Immunohistochemistry [E05.478.583]
- Immunologic Tests [E05.478.594]
- Antibody-Coated Bacteria Test, Urinary [E05.478.594.049]
- Basophil Degranulation Test [E05.478.594.100]
- Cell Migration Assays [E05.478.594.122]
- Cytotoxicity Tests, Immunologic [E05.478.594.160]
- Hemolytic Plaque Technique [E05.478.594.375]
- Histocompatibility Testing [E05.478.594.385]
- Immune Adherence Reaction [E05.478.594.400]
- Immunophenotyping [E05.478.594.450]
- Interferon-gamma Release Tests [E05.478.594.475]
- Leukocyte Adherence Inhibition Test [E05.478.594.500]
- Lymphocyte Activation [E05.478.594.530]
- Monitoring, Immunologic [E05.478.594.550]
- Pregnancy Tests, Immunologic [E05.478.594.662]
- Rosette Formation [E05.478.594.730]
- Serologic Tests [E05.478.594.760]
- Agglutination Tests [E05.478.594.760.050]
- AIDS Serodiagnosis [E05.478.594.760.060]
- Complement Fixation Tests [E05.478.594.760.150]
- Complement Hemolytic Activity Assay [E05.478.594.760.155]
- Hemadsorption Inhibition Tests [E05.478.594.760.360]
- Hemagglutination Inhibition Tests [E05.478.594.760.370]
- Neutralization Tests [E05.478.594.760.550]
- Precipitin Tests [E05.478.594.760.645]
- Radioallergosorbent Test [E05.478.594.760.830]
- Radioimmunoprecipitation Assay [E05.478.594.760.840]
- Serum Bactericidal Antibody Assay [E05.478.594.760.845]
- Syphilis Serodiagnosis [E05.478.594.760.850]
- Serotyping [E05.478.594.780]
- Skin Tests [E05.478.594.890]
- Immunoprecipitation [E05.478.605]
- Immunosuppression [E05.478.610]
- Interferon-gamma Release Tests [E05.478.707]
- Radioimmunodetection [E05.478.805]
- Indicator Dilution Techniques [E05.484]
- Interferometry [E05.490]
- Intubation [E05.497]
- Ischemic Preconditioning [E05.516]
- Isotope Labeling [E05.522]
- Magnetometry [E05.540]
- Manometry [E05.559]
- Materials Testing [E05.570]
- Methods [E05.581]
- Observation [E05.581.249]
- Research Design [E05.581.500]
- Control Groups [E05.581.500.149]
- Double-Blind Method [E05.581.500.300]
- Early Termination of Clinical Trials [E05.581.500.400]
- Meta-Analysis as Topic [E05.581.500.501]
- Numbers Needed To Treat [E05.581.500.577]
- Patient Selection [E05.581.500.653]
- Random Allocation [E05.581.500.805]
- Sample Size [E05.581.500.902]
- Microchip Analytical Procedures [E05.588]
- Micromanipulation [E05.591]
- Microscopy [E05.595]
- Microscopy, Acoustic [E05.595.370]
- Microscopy, Confocal [E05.595.395]
- Microscopy, Electron [E05.595.402]
- Microscopy, Fluorescence [E05.595.458]
- Microscopy, Interference [E05.595.513]
- Microscopy, Polarization [E05.595.624]
- Microscopy, Scanning Probe [E05.595.666]
- Microscopy, Ultraviolet [E05.595.680]
- Microscopy, Video [E05.595.690]
- Nuclear Microscopy [E05.595.744]
- Photomicrography [E05.595.799]
- Models, Animal [E05.598]
- Disease Models, Animal [E05.598.500]
- Models, Theoretical [E05.599]
- Fractals [E05.599.125]
- Fuzzy Logic [E05.599.250]
- Models, Biological [E05.599.395]
- Models, Chemical [E05.599.495]
- Models, Educational [E05.599.545]
- Models, Molecular [E05.599.595]
- Models, Nursing [E05.599.645]
- Models, Organizational [E05.599.670]
- Models, Psychological [E05.599.695]
- Models, Statistical [E05.599.835]
- Nonlinear Dynamics [E05.599.850]
- Molecular Probe Techniques [E05.601]
- Biosensing Techniques [E05.601.123]
- Blotting, Northern [E05.601.140]
- Blotting, Southern [E05.601.150]
- Blotting, Southwestern [E05.601.152]
- Branched DNA Signal Amplification Assay [E05.601.300]
- Immunoassay [E05.601.495]
- Molecular Imaging [E05.601.567]
- Oligonucleotide Array Sequence Analysis [E05.601.640]
- Protein Array Analysis [E05.601.680]
- Protein Interaction Mapping [E05.601.690]
- Random Amplified Polymorphic DNA Technique [E05.601.700]
- Neoplasm Transplantation [E05.624]
- Neuroimaging [E05.629]
- Neuromuscular Blockade [E05.635]
- Olfactometry [E05.638]
- Optical Imaging [E05.642]
- Optical Tweezers [E05.650]
- Oscillometry [E05.654]
- Parabiosis [E05.660]
- Perfusion [E05.680]
- Photoacoustic Techniques [E05.696]
- Photography [E05.712]
- Physical Stimulation [E05.723]
- Physiognomy [E05.734]
- Preservation, Biological [E05.760]
- Protein Refolding [E05.790]
- Protein Unfolding [E05.793]
- Radiometry [E05.799]
- Autoradiography [E05.799.256]
- Radiation Dosage [E05.799.513]
- Radiation Monitoring [E05.799.638]
- Radiometric Dating [E05.799.669]
- Scintillation Counting [E05.799.700]
- Spectrometry, Gamma [E05.799.801]
- Spectrometry, X-Ray Emission [E05.799.830]
- Sun Protection Factor [E05.799.890]
- Whole-Body Counting [E05.799.950]
- Reproductive Techniques [E05.820]
- Breeding [E05.820.150]
- Cloning, Organism [E05.820.180]
- Embryo Disposition [E05.820.240]
- Fallopian Tube Patency Tests [E05.820.390]
- Nuclear Transfer Techniques [E05.820.540]
- Ovulation Detection [E05.820.690]
- Ovulation Prediction [E05.820.745]
- Reproductive Techniques, Assisted [E05.820.800]
- Embryo Transfer [E05.820.800.500]
- Fertility Preservation [E05.820.800.625]
- Fertilization in Vitro [E05.820.800.750]
- Gamete Intrafallopian Transfer [E05.820.800.875]
- In Vitro Oocyte Maturation Techniques [E05.820.800.906]
- Insemination, Artificial [E05.820.800.937]
- Oocyte Donation [E05.820.800.968]
- Oocyte Retrieval [E05.820.800.976]
- Ovulation Induction [E05.820.800.984]
- Posthumous Conception [E05.820.800.986]
- Sperm Retrieval [E05.820.800.988]
- Zygote Intrafallopian Transfer [E05.820.800.992]
- Rheology [E05.830]
- Sonication [E05.848]
- Sound Spectrography [E05.855]
- Stereotaxic Techniques [E05.873]
- Substance Abuse Detection [E05.885]
- Technology, Pharmaceutical [E05.916]
- Chemistry Techniques, Synthetic [E05.916.039]
- Click Chemistry [E05.916.079]
- Dosage Forms [E05.916.250]
- Drug Compounding [E05.916.270]
- Drug Incompatibility [E05.916.290]
- Drug Labeling [E05.916.310]
- Drug Packaging [E05.916.320]
- Drug Stability [E05.916.330]
- Drug Storage [E05.916.350]
- Enzyme Stability [E05.916.360]
- High-Throughput Screening Assays [E05.916.680]
- Solid-Phase Synthesis Techniques [E05.916.840]
- Technology, Radiologic [E05.920]
- Telemetry [E05.925]
- Therapeutic Irrigation [E05.927]
- Thermometry [E05.933]
- Toxicity Tests [E05.940]
- Carcinogenicity Tests [E05.940.150]
- Cytotoxicity Tests, Immunologic [E05.940.245]
- Inhibitory Concentration 50 [E05.940.350]
- Lethal Dose 50 [E05.940.402]
- Maximum Tolerated Dose [E05.940.481]
- Mutagenicity Tests [E05.940.560]
- No-Observed-Adverse-Effect Level [E05.940.600]
- Toxicity Tests, Acute [E05.940.790]
- Toxicity Tests, Chronic [E05.940.800]
- Toxicity Tests, Subacute [E05.940.850]
- Toxicity Tests, Subchronic [E05.940.900]
- Trauma Severity Indices [E05.944]
- Wavelet Analysis [E05.959]
- Weightlessness Countermeasures [E05.974]
- Weightlessness Simulation [E05.977]
- Weights and Measures [E05.978]
- Whole Body Imaging [E05.979]
- Whole-Body Irradiation [E05.980]